Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new study in brain health is set to begin this summer extending research into former rugby players' health being undertaken at the University of Oxford.

Rugby player on the ground
Rugby player on the ground

University researchers within the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science (NDORMS) have been recruiting former rugby players since early 2015, including former English International players and former Oxbridge Blues.

The player health study is being undertaken within the Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis, and a subset of players will be re-contacted to participate in this new neurological study.

Lead researcher and NDORMS PhD student Madi Davies commented: "This is an excellent opportunity to build on what we are learning from our former players about their musculoskeletal and overall health. Our data is beginning to provide us with a clearer picture of player health long-term, and concussion is one aspect of many that need to be expanded in terms of what is currently known, and not yet known within rugby union."

Data analysis from this Phase 1 Player Health Study is underway and results are expected to be released later this autumn.

Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis Deputy Director and Professor of Rheumatology, Nigel Arden added: "The Arthritis Research UK Centre for Sport is examining player health across many sports, with a view to understanding the health benefits and deficits which may affect players in later life. We are thrilled to be joining forces in this collaboration to further examine cognition, mobility and health amongst this unique group".

In addition to having recruited former England players, researchers are also keen to hear from former recreational players. Madi Davies says: "As we look forward to the next phase of this study, we are keen to understand not only elite but equally how recreational players may be functioning in later life. Recreational players are the majority of players, and also those who are contributing to a potential health burden here."

Any former rugby player wishing to take part in this study can email therugbystudy@ndorms.ox.ac.uk for further information.

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8th October 2026.

Adam Croft appointed Norman Collisson Professor of Musculoskeletal Science

This appointment brings a further focus to linking rheumatology discovery science and clinical trials in NDORMS, strengthening translational rheumatology research across the department to deliver transformative treatments for patients with inflammatory arthritis.

NIHR fellowship to support national trial evaluating rehabilitation after kneecap dislocation

Dr Colin Forde has been awarded a National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Postdoctoral Award to lead a national study evaluating rehabilitation for people with a kneecap (patellar) dislocation.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Professor Afsie Sabokbar retires after more than 30 years at NDORMS

Botnar Institute Director of Graduate Studies, Professor Afsie Sabokbar, is retiring after more than 30 years at NDORMS.

Researchers funded to cure – rather than manage – inflammatory disease

Researchers from the Kennedy Institute of Rheumatology will join international partners in a bid to transform how chronic inflammatory disease is treated.